+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Embolization Particle Market by Product Type, Application, End Use, Embolic Material, Mode of Action - Global Forecast to 2030- Product Image
Embolization Particle Market by Product Type, Application, End Use, Embolic Material, Mode of Action - Global Forecast to 2030- Product Image
Sale

Embolization Particle Market by Product Type, Application, End Use, Embolic Material, Mode of Action - Global Forecast to 2030

  • PDF Icon

    Report

  • 197 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6015269
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The embolization particle market is evolving rapidly, serving as a key enabler for modern minimally invasive therapies and expanding clinical possibilities across specialized healthcare domains. With advancements driving both procedural outcomes and operational efficiencies, stakeholders face a dynamic ecosystem shaped by scientific progress and strategic realignments.

Market Snapshot: Embolization Particle Market Analysis

The Embolization Particle Market grew from USD 1.79 billion in 2024 to USD 2.00 billion in 2025. It is expected to continue growing at a CAGR of 11.10%, reaching USD 3.37 billion by 2030. This upward trajectory underscores sustained demand for novel embolic materials and optimized delivery technologies, driven by clinical adoption in oncology, neurology, and vascular interventions worldwide.

Scope & Segmentation

This research deep-dives into product, application, end-use, material, and action mode. The analysis also covers regional trends and industry-leading manufacturers, supporting both competitive benchmarking and strategic planning initiatives.

  • Product Types: Gelatin sponge particles, liquid embolic systems, microspheres, polyvinyl alcohol particles
  • Applications: Hepatic oncology, neurovascular procedures, peripheral arterial embolization, prostate artery embolization, uterine fibroid embolization
  • End Uses: Ambulatory surgical centers, hospitals, specialty clinics
  • Embolic Materials: Natural (collagen, gelatin) and synthetic (acrylic polymers, polyvinyl alcohol) particles
  • Mode of Action: Permanent and temporary embolic agents
  • Regions Analyzed: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (with coverage across 20+ countries), Asia-Pacific (featuring China, India, Japan, Australia, and several Southeast Asian markets)
  • Key Companies: Boston Scientific Corporation, Terumo Corporation, Merit Medical Systems, Sirtex Medical Limited, Guerbet Group, AngioDynamics

Key Takeaways for Senior Decision-Makers

  • Advances in polymer chemistry and nano-fabrication techniques are enabling real-time, physiologically responsive particles and heightened manufacturing control, translating into improved outcomes and expanded therapeutic use.
  • Integration of digital imaging and augmented reality is supporting greater procedural accuracy, reducing off-target effects and optimizing practitioner confidence in high-stakes interventions.
  • Efforts to improve supply chain resilience, including alternative sourcing and long-term supplier contracts, are now central to operations as cost structures and availability remain in flux.
  • Biodegradable and bioresorbable material innovation is gaining traction as providers seek solutions aligned with long-term safety, imaging clarity, and operational efficiency.
  • Segmented adoption patterns reflect differing user priorities, with ambulatory centers seeking cost-containment and flexibility while hospitals lean on comprehensive, complex care capabilities. Specialist clinics are targeting applications that require high customization and unique device profiles.

Tariff Impact: US Trade Policy Shaping Market Operations

The implementation of new US tariffs in 2025 is driving reevaluation across the embolization particle supply chain. Manufacturers are adjusting sourcing strategies and enhancing domestic production to address tariff-linked pricing shifts. Both upstream and downstream collaborations increase, as companies aim to buffer against volatility and maintain competitiveness. Adapting to new compliance requirements and regulatory classifications is now a priority, with operational agility and diversified supplier relationships essential to mitigate risk and ensure product continuity.

Methodology & Data Sources

This report uses a rigorous, triangulated methodology integrating literature reviews, regulatory filings, and structured stakeholder interviews. Quantitative insights are validated through surveys across manufacturers, providers, and distributors, complemented by trend analysis for market validation. Each insight is carefully peer-reviewed to align with current and near-term market realities.

Why This Report Matters

  • Enable strategic market positioning with clear, actionable segmentation and trend analysis.
  • Inform decision-making with the latest insights into product innovation, regulatory developments, and trade policy impacts.
  • Equip stakeholders with practical guidance to optimize portfolio management, supply chain strategies, and regional go-to-market approaches.

Conclusion

The embolization particle market is defined by convergence in material innovation, digital integration, and adaptive supply strategies. Organizations that align investments and partnerships to these shifts are positioned to capitalize on emerging opportunities and deliver lasting clinical value.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Embolization Particle Market, by Product Type
8.1. Introduction
8.2. Gelatin Sponge Particles
8.3. Liquid Embolic Systems
8.4. Microspheres
8.5. Polyvinyl Alcohol Particles
9. Embolization Particle Market, by Application
9.1. Introduction
9.2. Hepatic Oncology
9.3. Neurovascular Procedures
9.4. Peripheral Arterial Embolization
9.5. Prostate Artery Embolization
9.6. Uterine Fibroid Embolization
10. Embolization Particle Market, by End Use
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Hospitals
10.4. Specialty Clinics
11. Embolization Particle Market, by Embolic Material
11.1. Introduction
11.2. Natural Materials
11.2.1. Collagen
11.2.2. Gelatin
11.3. Synthetic Materials
11.3.1. Acrylic Polymers
11.3.2. Polyvinyl Alcohol
12. Embolization Particle Market, by Mode of Action
12.1. Introduction
12.2. Permanent
12.3. Temporary
13. Americas Embolization Particle Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Embolization Particle Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Embolization Particle Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Boston Scientific Corporation
16.3.2. Terumo Corporation
16.3.3. Merit Medical Systems, Inc.
16.3.4. Sirtex Medical Limited
16.3.5. Guerbet Group SA
16.3.6. AngioDynamics, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. EMBOLIZATION PARTICLE MARKET MULTI-CURRENCY
FIGURE 2. EMBOLIZATION PARTICLE MARKET MULTI-LANGUAGE
FIGURE 3. EMBOLIZATION PARTICLE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EMBOLIZATION PARTICLE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. EMBOLIZATION PARTICLE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. EMBOLIZATION PARTICLE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY GELATIN SPONGE PARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY LIQUID EMBOLIC SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY MICROSPHERES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY POLYVINYL ALCOHOL PARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY HEPATIC ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY NEUROVASCULAR PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PERIPHERAL ARTERIAL EMBOLIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PROSTATE ARTERY EMBOLIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY UTERINE FIBROID EMBOLIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY COLLAGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY GELATIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY ACRYLIC POLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY POLYVINYL ALCOHOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PERMANENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY TEMPORARY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 49. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 50. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 52. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 53. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 54. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 55. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 56. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 57. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 59. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 60. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 61. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 62. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 85. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 88. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 89. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 90. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 91. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 92. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 93. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 95. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 96. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 97. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 98. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 99. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 100. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 102. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 103. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 104. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 105. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 106. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 107. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 109. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 110. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 111. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 112. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 113. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 114. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 116. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 117. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 118. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 119. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 120. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 121. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 123. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 124. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 125. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 126. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 127. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 128. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 130. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 131. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 132. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 133. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 134. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 135. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 137. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 138. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 139. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 140. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 141. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 142. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 144. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 145. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 146. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 147. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 148. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 151. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 152. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 153. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 154. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 155. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 156. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 158. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 159. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 160. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 161. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 162. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 163. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 165. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 166. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 167. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 168. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 169. FINLAND EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 170. FINLAND EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. FINLAND EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 172. FINLAND EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 173. FINLAND EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 174. FINLAND EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 175. FINLAND EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. SWEDEN EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 180. SWEDEN EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 182. SWEDEN EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 183. NIGERIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 184. NIGERIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. NIGERIA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 186. NIGERIA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 187. NIGERIA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 188. NIGERIA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 189. NIGERIA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 190. EGYPT EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 191. EGYPT EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. EGYPT EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 193. EGYPT EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 194. EGYPT EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 195. EGYPT EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 196. EGYPT EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 197. TURKEY EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 198. TURKEY EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. TURKEY EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 200. TURKEY EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 201. TURKEY EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 202. TURKEY EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 203. TURKEY EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 204. ISRAEL EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 205. ISRAEL EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. ISRAEL EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 207. ISRAEL EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 208. ISRAEL EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 209. ISRAEL EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 210. ISRAEL EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 211. NORWAY EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 212. NORWAY EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. NORWAY EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 214. NORWAY EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 215. NORWAY EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 216. NORWAY EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 217. NORWAY EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 218. POLAND EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 219. POLAND EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. POLAND EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 221. POLAND EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 222. POLAND EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 223. POLAND EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 224. POLAND EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 225. SWITZERLAND EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 226. SWITZERLAND EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. SWITZERLAND EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 228. SWITZERLAND EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 229. SWITZERLAND EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 230. SWITZERLAND EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 231. SWITZERLAND EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 232. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 233. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 240. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 241. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 242. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 243. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 244. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 245. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 246. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 247. INDIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 248. INDIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. INDIA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 250. INDIA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 251. INDIA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 252. INDIA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 253. INDIA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 254. JAPAN EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 255. JAPAN EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. JAPAN EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 257. JAPAN EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 258. JAPAN EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 259. JAPAN EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 260. JAPAN EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 261. AUSTRALIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 262. AUSTRALIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 263. AUSTRALIA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 264. AUSTRALIA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 265. AUSTRALIA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 266. AUSTRALIA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 267. AUSTRALIA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 268. SOUTH KOREA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 269. SOUTH KOREA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 270. SOUTH KOREA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 271. SOUTH KOREA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 272. SOUTH KOREA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 273. SOUTH KOREA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 274. SOUTH KOREA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 275. INDONESIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 276. INDONESIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 277. INDONESIA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 278. INDONESIA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 279. INDONESIA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 280. INDONESIA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 281. INDONESIA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 282. THAILAND EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 283. THAILAND EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 284. THAILAND EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 285. THAILAND EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 286. THAILAND EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 287. THAILAND EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 288. THAILAND EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 289. PHILIPPINES EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 290. PHILIPPINES EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 291. PHILIPPINES EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 292. PHILIPPINES EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 293. PHILIPPINES EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 294. PHILIPPINES EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 295. PHILIPPINES EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 296. MALAYSIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 297. MALAYSIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 298. MALAYSIA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 299. MALAYSIA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 300. MALAYSIA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 301. MALAYSIA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 302. MALAYSIA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 303. SINGAPORE EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 304. SINGAPORE EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 305. SINGAPORE EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 306. SINGAPORE EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 307. SINGAPORE EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 308. SINGAPORE EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 309. SINGAPORE EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 310. VIETNAM EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 311. VIETNAM EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 312. VIETNAM EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 313. VIETNAM EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 314. VIETNAM EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 315. VIETNAM EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 316. VIETNAM EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 317. TAIWAN EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 318. TAIWAN EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 319. TAIWAN EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 320. TAIWAN EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2030 (USD MILLION)
TABLE 321. TAIWAN EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 322. TAIWAN EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 323. TAIWAN EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 324. EMBOLIZATION PARTICLE MARKET SHARE, BY KEY PLAYER, 2024
TABLE 325. EMBOLIZATION PARTICLE MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Embolization Particle market report include:
  • Boston Scientific Corporation
  • Terumo Corporation
  • Merit Medical Systems, Inc.
  • Sirtex Medical Limited
  • Guerbet Group SA
  • AngioDynamics, Inc.

Table Information

Report AttributeDetails
No. of Pages197
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.37 Billion
Compound Annual Growth Rate11.1%
Regions CoveredGlobal
No. of Companies Mentioned7

Related Topics

Related Reports

Vascular Embolization Market by Product Type, Application, End User - Global Forecast to 2030 - Product Image

Vascular Embolization Market by Product Type, Application, End User - Global Forecast to 2030

  • Report
  • 184 Pages
  • Global
From
Vascular Embolization Market Report 2025 - Product Image

Vascular Embolization Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Embolization Particles Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 - Product Image

Embolization Particles Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036

  • Report
  • 53 Pages
  • Global
From
Detachable Coil Embolization System Market by End User, Delivery Mechanism, Configuration, Application, Coil Type - Global Forecast to 2030 - Product Image

Detachable Coil Embolization System Market by End User, Delivery Mechanism, Configuration, Application, Coil Type - Global Forecast to 2030

  • Report
  • 192 Pages
  • Global
From
Uterine Fibroid Embolization Agent Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Uterine Fibroid Embolization Agent Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 77 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.